Capecitabine in combination with Docetaxel in first line in HER2-Negative metastatic breast cancer: an observational study

Kószó Renáta Lilla and Sántha Dóra and Büdi László and Erfán József and Győrfy Károly and Horváth Zsolt and Kocsis Judit and Landherr László and Hitre Erika and Máhr Károly and Pajkos Gábor and Pápai Zsuzsanna and Kahán Zsuzsanna: Capecitabine in combination with Docetaxel in first line in HER2-Negative metastatic breast cancer: an observational study.
PATHOLOGY AND ONCOLOGY RESEARCH, 23 (3). pp. 505-511. ISSN 1219-4956 (2017)

[thumbnail of s12253_016_0129_7_u.pdf]
Preview
Text
s12253_016_0129_7_u.pdf - Published Version

Download (362kB) | Preview
Item Type: Journal Article
Journal or Publication Title: PATHOLOGY AND ONCOLOGY RESEARCH
Date: 2017
Volume: 23
Number: 3
Page Range: pp. 505-511
ISSN: 1219-4956
Publisher: Springer Netherlands
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3151638
DOI azonosító: https://doi.org/10.1007/s12253-016-0129-7
Date Deposited: 2018. Jan. 08. 10:17
Last Modified: 2020. Mar. 03. 16:00
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12504

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year